CHANGMAO BIOCHEMICAL ENGINEERING COMPANY LIMITED

Changmao Biochemical Engineering Company Limited

954 CNE100000106

Commodity Chemicals

Market Closed - Hong Kong S.E. Other stock markets 04:08:16 2024-05-02 am EDT			5-day change	1st Jan Change
0.41 ^HKD	0.00%		+5.13%	-30.51%

Mar. 26	Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 29	Changmao Biochemical Engineering to Swing to Loss in 2023	MT

Changmao Biochemical Engineering Company Limited Provides Consolidated Net Profit Attributable Guidance for the Six Months Ended 30 June 2023

August 01, 2023 at 04:54 am EDT

Changmao Biochemical Engineering Company Limited Provided consolidated net profit attributable to the shareholders of the Company for the six months ended 30 June 2023 of less than RMB 5,000,000, which represents a significant decline as compared with the consolidated net profit attributable to the shareholders of the Company of approximately RMB 40,880,000 for the six months ended 30 June 2022.

Latest news about Changmao Biochemical Engineering Company Limited

Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Changmao Biochemical Engineering to Swing to Loss in 2023	Feb. 29	MT
Changmao Biochemical Engineering Company Limited Provides Earnings Guidance for the Year December 31, 2023	Feb. 29	CI
Changmao Biochemical Unit Seeks 200 Million Yuan Bank Loan to Boost Factory Capacity	23-09-13	MT
Changmao Biochemical Engineering’s Profit Down 90% in H1	23-08-18	MT
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Changmao Biochemical Engineering's Profit to Drop in H1	23-08-02	MT
Changmao Biochemical Engineering Company Limited Provides Consolidated Net Profit Attributable Guidance for the Six Months Ended 30 June 2023	23-08-01	CI
Changmao Biochemical Engineering Company Limited approves Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023	23-05-18	CI
Changmao Biochemical Engineering Company Limited Recommends Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023	23-03-28	CI
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Changmao Biochemical Engineering Company Limited Announces Change of Chairman of Remuneration and Appraisal Committee	23-03-28	CI
Changmao Biochemical Sees Rise in FY22 Profit	23-03-16	MT
Changmao Biochemical Engineering Company Limited Provides Earnings Guidance for the Year 2022	23-03-16	CI
Changmao Biochemical Engineering Eyes Secondary Listing in Shenzhen	23-03-15	MT
Changmao Biochemical Engineering Company Limited Announces Appointment of Ms. Cheng Mun Wah as Independent Non-Executive Director and Chairman of Audit Committee, and Member of Remuneration Committee and Nomination Committee	22-08-29	CI
Changmao Biochemical Engineering's H1 Net Profit Jumps to $6 Million	22-08-19	MT
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-18	CI
Changmao Biochemical Sees Significant Increase in H1 Profit	22-08-05	MT
Changmao Biochemical Engineering Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022	22-08-05	CI
Changmao Biochemical Engineering Company Limited Appoints Cheng Mun Wah as Independent Non-Executive Director and Chairman of Audit Committee and Member of Remuneration Committee and Nomination Committee	22-06-30	CI
Changmao Biochemical Engineering Company Limited Approves Board Resignations, Effective 18 June 2022	22-05-25	CI
Changmao Biochemical Engineering Company Limited Omits Final Dividend for the Year Ended 31 December 2021	22-04-21	CI
Changmao Biochemical Engineering Company Limited Announces Board and Executive Changes	22-04-21	CI
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI

Chart Changmao Biochemical Engineering Company Limited

Duration

Period

Chart Changmao Biochemical Engineering Company Limited

More charts

Company Profile

Changmao Biochemical Engineering Company Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of organic acids. The main products of the Company include organic acids and their derivatives with four carbons in structures. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L-tartaric acid, D-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. Its products are mainly sold to food additive industries, chemical industries and pharmaceutical industries. The Company operates businesses in Mainland China, Europe, Asia Pacific, America and other regions.

Sector

Commodity Chemicals

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Commodity Chemicals

	1st Jan change	Capi.
CHANGMAO BIOCHEMICAL ENGINEERING COMPANY LIMITED	-30.51%	27.76M
AIR LIQUIDE	+2.80%	103B
SAUDI BASIC INDUSTRIES CORPORATION	+1.20%	67.05B
PT CHANDRA ASRI PACIFIC TBK	+44.29%	40.4B
WANHUA CHEMICAL GROUP CO., LTD.	+15.99%	38.64B
LYONDELLBASELL INDUSTRIES N.V.	+3.71%	32.41B
WESTLAKE CORPORATION	+6.27%	19.17B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+12.32%	16.76B
HENGLI PETROCHEMICAL CO.,LTD.	+17.69%	15.07B
RONGSHENG PETROCHEMICAL CO., LTD.	+8.31%	14.82B